Inside Innovation

At Life Science Washington’s 2022 Medical Device Summit investors, regulatory experts and CEOs shared their expertise and advice on breaking through as an entrepreneur in

Seattle-based biotech Bonum Therapeutics recently announced a $93 million Series A funding round, with participation from Rivervest Venture Partners, Roche Venture Fund, Digitalis Ventures, 3×5

Two Washington-based biotechs have made BioSpace’s 2023 Best Places to Work report. Seattle-based Sana Biotechnology has been voted the best place to work in the

The healthcare and life sciences private and public sectors have helped prevent the U.S. from plummeting into a deep recession through commercialization and job creation.

Spokane-based startup Gestalt Diagnostics recently received eight patents in the United Kingdom for its PathFlow software that replaces glass slides and microscopes with data-rich digital

At the 2022 American Society of Nephrology’s Kidney Week, Seattle-based Chinook Therapeutics recently shared data from their Phase I/II trial evaluating BION-1301, a novel anti-APRIL

A Seattle-based startup, Intrinsic Medicine, is merging with Phoenix Biotech Acquisition Corp (PBAX), a special purpose acquisition company or SPAC. The deal is anticipated to

Truveta, a startup co-founded by former Microsoft executive Terry Myerson and backed by four national health systems to build the world’s largest healthcare data set,

Google recently acquired Sound Life Sciences, a spinout of The University of Washington that developed an app to monitor breathing. The company uses sonar technology

According to a new report on the U.S. News & World’s Best Global Universities rankings, the University of Washington (UW) is the 6th best university

Nearly $5.1 billion was invested in Washington state’s biotechnology and life science companies last year, according to Life Science Washington’s 2021 Washington State Investor Report.

Seattle-area startup Viome Life Sciences secured $67 million in funding, increasing its total capital raise to over $125 million. The company sells kits that determine